Venture Capital Deals and Investments
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Venture Capital Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
BridGene Biosciences Raises $28M Series B+ Led by Bayland Capital
Series BVenture Capital

BridGene Biosciences Raises $28M Series B+ Led by Bayland Capital

•October 16, 2025
•Oct 16, 2025
0

Participants

BridGene Biosciences

BridGene Biosciences

company

Biotechnology Innovation Organization

Biotechnology Innovation Organization

investor

ZoomInfo

ZoomInfo

investor

Deal Summary

BridGene Biosciences closed a $28M Series B+ financing led by Bayland Capital with participation from GTJA Investment Group, Proxima Ventures, and existing investors Lapam Capital and Grains Valley Venture Capital. The funds will support the company's discovery and development of small-molecule drugs for hard-to-drug targets.

0

Comments

Want to join the conversation?

Loading comments...